WeChat Mini Program
Old Version Features

Final 10-Year Results of the Breast International Group 2–98 Phase III Trial and the Role of Ki67 in Predicting Benefit of Adjuvant Docetaxel in Patients with Oestrogen Receptor Positive Breast Cancer

Amir Sonnenblick,Prudence A. Francis,Hatem A. Azim,Evandro de Azambuja,Bo Nordenskjold,Jorge Gutierez,Emmanuel Quinaux,Mauro G. Mastropasqua,Lieveke Ameye, Michael Anderson,Ana Lluch,Michael Gnant,Aron Goldhirsch,Angelo Di Leo,Agusti Barnadas,Hernan Cortes-Funes,Martine Piccart,John Crown

EUROPEAN JOURNAL OF CANCER（2015）

Cited 35|Views62
Key words
Ki67,Adjuvant taxanes,ER positive,Breast cancer,Pooled analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined